The Coronavirus Has Infected More Than Half of Americans, the C.D.C. Reports

CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing

Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission

Why Are Lots of Kids Likely to be Sick This Holiday Season?

How Many Times Will You Get COVID?

Mount Sinai Announces the Formation of CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics, Targeting Pandemic Threats and Diseases of Unmet Medical Need

Nasal vaccines may be the next generation of protection against COVID

Why do some people seem unable to catch COVID? Scientists are looking for answers

Scientific Consortium Established by National Institutes of Health Provides Real-Time Risk Assessment of SARS-CoV-2 Variants on Immune Protection

The Covid Vaccine We Need Now May Not Be a Shot

Easier to produce COVID vaccine shows promise in trials; nasal spray vaccine booster works in mice